Abbott Laboratories to pay $385 million over contaminated infant-formula plant
AI Summary- Abbott Laboratories will pay $385 million to settle allegations over its infant-formula manufacturing plant.
- $385 million includes nearly $349 million for the federal government and just over $36 million for states.
- The facility closed in February 2022 and reopened in June after FDA inspections found unsanitary conditions.